301 studies found for:    Open Studies | "Urinary Bladder Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
Conditions: Locally Advanced or Metastatic Urothelial Cell Carcinoma;   Urinary Bladder Disease;   Urological Diseases
Interventions: Drug: B-701;   Drug: Docetaxel;   Drug: placebo
2 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Overactive Bladder;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
3 Recruiting A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Intervention: Drug: Betmiga®
4 Recruiting This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases\Urologic Diseases
Interventions: Drug: Solifenacin Succinate;   Drug: Mirabegron;   Drug: Placebo
5 Not yet recruiting 3D HD Versus 2D HD in Cholecystectomy
Conditions: Cholelithiasis;   Gall Bladder Disease
Interventions: Device: 3D HD laparoscopy;   Device: 2D HD laparoscopy
6 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
7 Not yet recruiting Vicinium Treatment for Subjects With High-grade Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Condition: Bladder Cancer
Intervention: Biological: Vicinium
8 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
9 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
10 Recruiting Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC
Condition: Carcinoma of Urinary Bladder, Superficial
Interventions: Device: 40 mg MMC gel;   Other: Standard of care MMC mixed with water;   Device: 80 mg MMC gel
11 Recruiting Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB
Condition: Overactive Bladder
Interventions: Drug: THVD-201;   Drug: Placebo(For THVD-201);   Drug: Detrusitol 2mg tablet;   Drug: Placebo(For Detrusitol 2mg tablet)
12 Recruiting Cystoscopic Ablation Via RF Energy Clinical Trial (CARET 2)
Condition: Overactive Bladder
Intervention: Device: Amphora OAB Device 3.0 mm
13 Not yet recruiting MPDL3280A-treatment-IST-UMCG
Conditions: Bladder Cancer;   Non Small Cell Lung Cancer;   Breast Cancer
Intervention: Drug: MPDL3280A
14 Not yet recruiting Brain Areas Involved in Bladder Filling and Contraction
Condition: Urinary Bladder, Overactive
Interventions: Procedure: Uroflowmetry;   Device: fMRI
15 Not yet recruiting RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)
Condition: Bladder Cancer
Intervention: Other: Synergo® RITE + MMC
16 Not yet recruiting Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.
Condition: Overactive Bladder
Intervention: Drug: mirabegron 50mg
17 Recruiting Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement
Conditions: Urinary Bladder, Overactive;   Pain;   Lower Urinary Tract Symptoms
Interventions: Drug: Mirabegron;   Drug: Placebo
18 Not yet recruiting Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging
Condition: Muscle-invasive Bladder Cancer
Intervention: Other: Whole-body FDG PET-CT
19 Recruiting T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Conditions: Bladder Carcinoma;   Breast Cancer;   Esophagus Carcinoma;   Lung Cancer;   Melanoma;   Multiple Myeloma;   Neuroblastoma;   Ovarian Cancer;   Synovial Sarcoma;   Other Metastatic Solid Cancers
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Anti-NY ESO-1 TCR-transduced T cells
20 Not yet recruiting MPDL3280A-imaging-IST-UMCG
Conditions: Breast Cancer;   Bladder Cancer;   Non Small Cell Lung Cancer
Intervention: Other: 89Zr-MPDL-3280A-PET scans

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years